TM editors' note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.

Following the long holiday weekend, Tuesday's markets overall have been a bit mixed. Despite hitting near all time highs last week the Nasdaq and other major indexes have given back previous gains on Tuesday morning. Even with this in mind, there are several stocks to watch on Tuesday morning including Benitec Biopharma (BNTC), Bonanza Creek Energy Inc. (BCEI), mCig Inc. (MCIG), and Pulmatrix, Inc. (PULM).

Benitec Biopharma looks like it has had a news catalyst behind it this morning. The company revealed in pre market news that it has been granted Orphan Drug Designation to BB-301 as an orphan medicinal product for the treatment of patients with oculopharyngeal muscular dystrophy. This comes from the European Commission based on positive recommendations from the European Medicines Agency Committee for Orphan Medicinal Products. Due to the rarity of the disease, current therapies on the market could be limited. David Suhy, Chief Scientific Officer of Benitec made comment to this, "We are very excited that BB-301 has received Orphan Drug Designation in Europe from the EMA COMP.This is a key program in our pipeline and we are happy to see the EMA recognising the urgent and unmet medical need for a safe and effective treatment for OPMD patients." Shares are up more than 70% prior to the lunch hour.

Bonanza Creek has also gotten off to a soaring start to the week. The company has been highlighted by several financial media outlets for the amount of stock indsiders have been buying. In an article from TheStreet, Roberto Pedone comments, "If you're bullish on Bonanza Creek Energy, then I would look for long-biased trades as long as this stock is trending above its 20-day moving average of $1.55 a share or above its previous breakout level of $1.42 a share and then once it breaks out above some near-term overhead resistance levels at $2.33 to $2.35 a share with volume that hits near or above its three-month average action of 3.63 million shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $3 to $3.25, or even $3.75 to $4 a share." Today the stock has traded as high as $3.19 in early trading.

mCig Inc. is another stock that has been on a race to new highs this year. Following the boom that the marijuana stock sector has seen since Tump was elected, mCig has also followed suit. The stock saw a mini rally in October and following the election, shares of mCig continue to climb higher. The stock hit highs of $0.435 and marking the 7th consecutive day the stock has held a bull trend. In their last announcement the company released data showing that it could in fact be on its way to its best quarter in the company's history.

Finally, shares of Pulmatrix have grabbed the attention of penny stock traders on Tuesday. The company announced this morning that it has received a designation of "Qualified Infectious Disease Product" (QIDP) from the FDA for it's drug candidate treating fungal infections in the lungs of CF patients. The candidate, PUR1900 is a product for inhalation use as a QIDPto treat pulmonary Aspergillus infections in CF patients. Despite being halted, shares continue to trade higher on Tuesday. After opening at $0.70, shares have reached a morning high of $1.79